NEW ISSUE
Special issue on PCR Valves e-Course; patient-centring the Heart Team, COVID and clinical trials...
Optimising the delivery of self-expanding valves according to vascular access
November 20, 2020
Showing 1-8 of 8 articles
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial
September 20, 2019 | 10.4244/EIJ-D-19-00325
Coronary interventions
Bioresorbable vascular scaffold versus Xience metallic stents: outcomes in the AIDA trial stratified by SYNTAX score May 7, 2019 | 10.4244/EIJ-D-18-00884
Coronary interventions
Implantation techniques (predilatation, sizing, and post-dilatation) and the incidence of scaffold thrombosis and revascularisation in lesions treated with an everolimus-eluting bioresorbable vascular scaffold: insights from the AIDA trial July 20, 2018 | 10.4244/EIJ-D-17-01152
Coronary interventions
Two-year clinical outcomes of Absorb bioresorbable vascular scaffold implantation in complex coronary artery disease patients stratified by SYNTAX score and ABSORB II study enrolment criteria August 5, 2016 | 10.4244/EIJV12I5A95
Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry
February 20, 2015 | 10.4244/EIJY14M08_08